309 related articles for article (PubMed ID: 17961827)
1. Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells.
Destito G; Yeh R; Rae CS; Finn MG; Manchester M
Chem Biol; 2007 Oct; 14(10):1152-62. PubMed ID: 17961827
[TBL] [Abstract][Full Text] [Related]
2. PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo.
Steinmetz NF; Manchester M
Biomacromolecules; 2009 Apr; 10(4):784-92. PubMed ID: 19281149
[TBL] [Abstract][Full Text] [Related]
3. Guiding plant virus particles to integrin-displaying cells.
Hovlid ML; Steinmetz NF; Laufer B; Lau JL; Kuzelka J; Wang Q; Hyypiä T; Nemerow GR; Kessler H; Manchester M; Finn MG
Nanoscale; 2012 Jun; 4(12):3698-705. PubMed ID: 22585108
[TBL] [Abstract][Full Text] [Related]
4. Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo.
Gonzalez MJ; Plummer EM; Rae CS; Manchester M
PLoS One; 2009 Nov; 4(11):e7981. PubMed ID: 19956734
[TBL] [Abstract][Full Text] [Related]
5. Cowpea Mosaic Virus Nanoparticles and Empty Virus-Like Particles Show Distinct but Overlapping Immunostimulatory Properties.
Wang C; Beiss V; Steinmetz NF
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375592
[TBL] [Abstract][Full Text] [Related]
6. Differential uptake of chemically modified cowpea mosaic virus nanoparticles in macrophage subpopulations present in inflammatory and tumor microenvironments.
Agrawal A; Manchester M
Biomacromolecules; 2012 Oct; 13(10):3320-6. PubMed ID: 22963597
[TBL] [Abstract][Full Text] [Related]
7. Development of copper-catalyzed azide-alkyne cycloaddition for increased in vivo efficacy of interferon β-1b by site-specific PEGylation.
Nairn NW; Shanebeck KD; Wang A; Graddis TJ; VanBrunt MP; Thornton KC; Grabstein K
Bioconjug Chem; 2012 Oct; 23(10):2087-97. PubMed ID: 22988919
[TBL] [Abstract][Full Text] [Related]
8. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.
Murray AA; Wang C; Fiering S; Steinmetz NF
Mol Pharm; 2018 Sep; 15(9):3700-3716. PubMed ID: 29798673
[TBL] [Abstract][Full Text] [Related]
9. Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy.
Beiss V; Mao C; Fiering SN; Steinmetz NF
Mol Pharm; 2022 May; 19(5):1573-1585. PubMed ID: 35333531
[TBL] [Abstract][Full Text] [Related]
10. Cowpea mosaic virus nanoparticles for cancer imaging and therapy.
Beatty PH; Lewis JD
Adv Drug Deliv Rev; 2019 May; 145():130-144. PubMed ID: 31004625
[TBL] [Abstract][Full Text] [Related]
11. Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin.
Koudelka KJ; Destito G; Plummer EM; Trauger SA; Siuzdak G; Manchester M
PLoS Pathog; 2009 May; 5(5):e1000417. PubMed ID: 19412526
[TBL] [Abstract][Full Text] [Related]
12. Development of viral nanoparticles for efficient intracellular delivery.
Wu Z; Chen K; Yildiz I; Dirksen A; Fischer R; Dawson PE; Steinmetz NF
Nanoscale; 2012 Jun; 4(11):3567-76. PubMed ID: 22508503
[TBL] [Abstract][Full Text] [Related]
13. Interaction between a 54-kilodalton mammalian cell surface protein and cowpea mosaic virus.
Koudelka KJ; Rae CS; Gonzalez MJ; Manchester M
J Virol; 2007 Feb; 81(4):1632-40. PubMed ID: 17121801
[TBL] [Abstract][Full Text] [Related]
14. Metastatic Colon Cancer Treatment Using S100A9-Targeted Cowpea Mosaic Virus Nanoparticles.
Chung YH; Volckaert BA; Steinmetz NF
Biomacromolecules; 2022 Dec; 23(12):5127-5136. PubMed ID: 36375170
[TBL] [Abstract][Full Text] [Related]
15. Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery.
Yildiz I; Lee KL; Chen K; Shukla S; Steinmetz NF
J Control Release; 2013 Dec; 172(2):568-78. PubMed ID: 23665254
[TBL] [Abstract][Full Text] [Related]
16. Combining high-resolution cryo-electron microscopy and mutagenesis to develop cowpea mosaic virus for bionanotechnology.
Meshcheriakova Y; Durrant A; Hesketh EL; Ranson NA; Lomonossoff GP
Biochem Soc Trans; 2017 Dec; 45(6):1263-1269. PubMed ID: 29101307
[TBL] [Abstract][Full Text] [Related]
17. Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.
Singh P; Prasuhn D; Yeh RM; Destito G; Rae CS; Osborn K; Finn MG; Manchester M
J Control Release; 2007 Jul; 120(1-2):41-50. PubMed ID: 17512998
[TBL] [Abstract][Full Text] [Related]
18. Chemical addressability of ultraviolet-inactivated viral nanoparticles (VNPs).
Rae C; Koudelka KJ; Destito G; Estrada MN; Gonzalez MJ; Manchester M
PLoS One; 2008 Oct; 3(10):e3315. PubMed ID: 18830402
[TBL] [Abstract][Full Text] [Related]
19. Evidence for participation of RNA 1-encoded elicitor in Cowpea mosaic virus-mediated concurrent protection.
Bruening G; Buzayan JM; Ferreiro C; Lim W
Virology; 2000 Jan; 266(2):299-309. PubMed ID: 10639316
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Fate of Cowpea Mosaic Virus In Situ Vaccine: Biodistribution and Clearance.
Affonso de Oliveira JF; Chan SK; Omole AO; Agrawal V; Steinmetz NF
ACS Nano; 2022 Nov; 16(11):18315-18328. PubMed ID: 36264973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
